HOME >> MEDICINE >> NEWS
Invitation to take part in one-on-one interviews with experts on Avandia

36th European Association for the Study of Diabetes (EASD) Annual Meeting, 17-21 September, 2000

On behalf of SmithKline Beecham we are delighted to be able to offer you exclusive interviews with leading experts on Avandia.

Monday 18 September, 2000
Tuesday 19 September, 2000

  • With the European approval of Avandia, SmithKline Beecham's new oral anti-diabetic agent, a new treatment option is available to patients with inadequately controlled type 2 diabetes.

  • Avandia is the first thiazolidinedione to receive centralized approval across the 15 countries of the European Union and has been approved in over 50 countries worldwide.

  • Avandia has been linked with improvements in -cell function and reductions in insulin resistance, both fundamental causes of type 2 diabetes.

  • To date, over 4 million Avandia prescriptions have been dispensed to over a million patients in the US alone.

We are delighted to be able to offer you the opportunity to interview some of the world's leading experts in diabetes in exclusive one-on-one interviews.


'"/>

Contact: Chloe Murray
chloe@meditech.co.uk
44-20-7398-0500
MediTech Media Ltd.
4-Sep-2000


Page: 1

Related medicine news :

1. Failure to count Iraqi casualties is irresponsible, say experts
2. International gathering of experts to share retinoblastoma breakthroughs
3. Injury toll in US homes tops 12 million yearly: UNC, other experts call for action
4. Assessing the season: LSU hurricane experts learned lessons during Hurricane Season 2004
5. Anniversary of one of the largest hepatitis A outbreaks in the US brings experts together
6. Rice cartilage experts win $1.5M NIH grant to bioengineer TMJ discs
7. Leading MRSA experts address emergence of superbug
8. Chest 2004 hosts world experts in pulmonary, sleep, and critical care medicine
9. Tobacco sponsorship of Formula One must stop, say health experts
10. Speech recognition experts at OGI School of Science & Engineering receive nearly $700,000 in grants
11. International experts discuss latest research on vitamin E & health

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Invitation take part one one interviews with experts Avandia

(Date:4/17/2014)... led by Cesar A. Arias, M.D., Ph.D., at The ... has identified a new superbug that caused a bloodstream ... the April 17 issue of The New England ... part of a class of highly-resistant bacteria known as ... a major cause of hospital and community-associated infections. The ...
(Date:4/17/2014)... improves general blood flow and alleviates muscle soreness ... at the University of Illinois at Chicago. , ... in the Archives of Physical Medicine and ... function in people who had not exercised, suggesting ... their level of physical activity. , Improved circulation ...
(Date:4/17/2014)... adrenaline after they suffer a cardiac arrest outside of ... long-term, according to new research conducted at St. Michael,s ... a cardiac arrest get adrenaline, which has been the ... Dr. Steve Lin, an emergency physician and trauma team ... treatment, long-term survival rates of patients who suffer a ...
(Date:4/16/2014)... , STANFORD, Calif. Consider the marvel of the embryo. ... shape and function as they multiply to become the cells ... tissues of the body. , Now, in a feat of ... the complex genetic coding that allows embryonic cells to proliferate ...
(Date:4/16/2014)... According to a new study, endoscopists, recommendations for ... to two small polyps are consistent with guideline recommendations ... an appropriate target for quality indicators. This is the ... guidelines for timing of repeat colonoscopy after one to ...
Breaking Medicine News(10 mins):Health News:New MRSA superbug emerges in Brazil 2Health News:Massage therapy improves circulation, eases muscle soreness 2Health News:Adrenaline does little to increase patient's survival after cardiac arrest 2Health News:Stanford scientists develop 'playbook' for reverse engineering tissue 2Health News:Stanford scientists develop 'playbook' for reverse engineering tissue 3Health News:Surveillance colonoscopy recommendations for average-risk patients with 1 to 2 small polyps consistent with guidelines 2Health News:Surveillance colonoscopy recommendations for average-risk patients with 1 to 2 small polyps consistent with guidelines 3
(Date:1/15/2014)... 15, 2014 Reportlinker.com announces that ... available in its catalogue: ... for Advanced Drug Delivery Systems -- ... http://www.reportlinker.com/p01941928/Global-Markets-and-Technologies-for-Advanced-Drug-Delivery-Systems----Focus-on-Routes-of-Administration.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology ...
(Date:1/15/2014)... wearable injector slightly larger than an Oreo cookie may soon ... drugs in the large doses required to treat a wide ... genetic disorders.  An emerging biologic drugs market ... analysts.   Many of these drugs will require a new type ...
(Date:1/14/2014)... Corporation (Nasdaq: LMNX ) today announced that it ... on Monday, February 3, 2014. A press release announcing the ... (Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO ) Management ... and financial results for the fourth quarter and twelve months ...
Breaking Medicine Technology:Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 16Enable Injections Presents A New Class of Injectors for Drug Delivery at PEPTalk, Drug Delivery Partnership Meetings 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 3
Cached News: